Stephana Patton
General Counsel bei CUTERA, INC.
Vermögen: 163 200 $ am 30.04.2024
Profil
Stephana E.
Patton is currently the Chief Legal Officer at Cutera, Inc. and Venn Biosciences Corp.
She previously held positions as the Head-Intellectual Property & Licensing at Salix Pharmaceuticals Ltd.
from 2007 to 2015, Secretary, Compliance Officer & General Counsel at Lineage Cell Therapeutics, Inc. from 2017 to 2019, Commercial Compliance Officer & General Counsel at BioDelivery Sciences International, Inc., Secretary & Chief Compliance Officer at Eiger BioPharmaceuticals, Inc. from 2019 to 2021, and Vice President-Intellectual Property & Licensing at Salix Pharmaceuticals, Inc. from 2007 to 2015.
Dr. Patton obtained a doctorate degree from Emory University, a graduate degree from Boston University School of Law, and an undergraduate degree from Erskine College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CUTERA, INC.
0,40% | 06.03.2024 | 80 000 ( 0,40% ) | 163 200 $ | 30.04.2024 |
| 13.05.2024 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Stephana Patton
| Unternehmen | Position | Beginn |
|---|---|---|
| CUTERA, INC. | General Counsel | 13.11.2023 |
Venn Biosciences Corp.
 Venn Biosciences Corp. BiotechnologyHealth Technology Venn Biosciences Corp. engages in developing an artificial intelligence-driven mass spectrometry discovery and validation platform. Its products include VENN Vista, a glycoproteomic analysis; OpenPIP software, a neural network for automated mass spectrometry peak integration; and cancer liquid biopsy. The company was founded by Lieza Denan, Aldo Carrascoso, Carlito B. Lebrilla, and Carolyn R. Bertozzi in June 2017 and is headquartered in South San Francisco, CA. | General Counsel | - |
Ehemalige bekannte Positionen von Stephana Patton
| Unternehmen | Position | Ende |
|---|---|---|
| EIGER BIOPHARMACEUTICALS, INC. | Compliance Officer | 01.04.2021 |
| LINEAGE CELL THERAPEUTICS, INC. | Compliance Officer | 01.03.2019 |
Salix Pharmaceuticals, Inc.
 Salix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Salix Pharmaceuticals Ltd., Salix Pharmaceuticals, Inc. is a company that manufactures pharmaceutical products. The company is based in Sunnyvale, CA. | Corporate Officer/Principal | 01.06.2015 |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Compliance Officer | - |
Ausbildung von Stephana Patton
| Emory University | Doctorate Degree |
| Erskine College | Undergraduate Degree |
| Boston University School of Law | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| LINEAGE CELL THERAPEUTICS, INC. | Health Technology |
| CUTERA, INC. | Health Technology |
| EIGER BIOPHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
BioDelivery Sciences International, Inc.
 BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology BioDelivery Sciences International, Inc. operates as a pharmaceutical company engaged in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. Its products include Symproic and Belbuca. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC. | Health Technology |
Salix Pharmaceuticals, Inc.
Salix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Salix Pharmaceuticals Ltd., Salix Pharmaceuticals, Inc. is a company that manufactures pharmaceutical products. The company is based in Sunnyvale, CA. | Health Technology |
Venn Biosciences Corp.
Venn Biosciences Corp. BiotechnologyHealth Technology Venn Biosciences Corp. engages in developing an artificial intelligence-driven mass spectrometry discovery and validation platform. Its products include VENN Vista, a glycoproteomic analysis; OpenPIP software, a neural network for automated mass spectrometry peak integration; and cancer liquid biopsy. The company was founded by Lieza Denan, Aldo Carrascoso, Carlito B. Lebrilla, and Carolyn R. Bertozzi in June 2017 and is headquartered in South San Francisco, CA. | Health Technology |
